B
Bailard’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.02M | Sell |
180,200
-130,000
| -42% | -$2.18M | 0.07% | 189 |
|
|
2025
Q1 | $4.77M | Buy |
310,200
+200
| +0.1% | +$3.07K | 0.12% | 133 |
|
|
2024
Q4 | $6.83M | Buy |
+310,000
| New | +$6.83M | 0.17% | 116 |
|
|
2020
Q3 | – | Sell |
-332,000
| Closed | -$4.09M | – | 615 |
|
|
2020
Q2 | $4.09M | Buy |
+332,000
| New | +$4.09M | 0.23% | 89 |
|
|
2019
Q2 | – | Sell |
-360,495
| Closed | -$5.65M | – | 602 |
|
|
2019
Q1 | $5.65M | Sell |
360,495
-36,005
| -9% | -$565K | 0.35% | 64 |
|
|
2018
Q4 | $6.11M | Buy |
396,500
+26,800
| +7% | +$413K | 0.41% | 56 |
|
|
2018
Q3 | $7.96M | Buy |
+369,700
| New | +$7.96M | 0.47% | 44 |
|
|
2016
Q4 | – | Sell |
-80,361
| Closed | -$3.7M | – | 325 |
|
|
2016
Q3 | $3.7M | Sell |
80,361
-80,045
| -50% | -$3.68M | 0.34% | 73 |
|
|
2016
Q2 | $8.06M | Sell |
160,406
-54,894
| -25% | -$2.76M | 0.96% | 16 |
|
|
2016
Q1 | $11.5M | Buy |
215,300
+65,300
| +44% | +$3.49M | 1.61% | 12 |
|
|
2015
Q4 | $9.85M | Sell |
150,000
-65,300
| -30% | -$4.29M | 4.33% | 1 |
|
|
2015
Q3 | $12.2M | Sell |
215,300
-35,000
| -14% | -$1.98M | 1.9% | 10 |
|
|
2015
Q2 | $14.8M | Hold |
250,300
| – | – | 2.29% | 7 |
|
|
2015
Q1 | $15.6M | Hold |
250,300
| – | – | 2.16% | 7 |
|
|
2014
Q4 | $14.4M | Buy |
250,300
+70,000
| +39% | +$4.03M | 2.03% | 7 |
|
|
2014
Q3 | $9.69M | Buy |
180,300
+110,100
| +157% | +$5.92M | 1.49% | 9 |
|
|
2014
Q2 | $3.68M | Buy |
+70,200
| New | +$3.68M | 0.57% | 27 |
|